Dexzopiclone has shown toxic effects on the fetus in animal experiments and may cause malformations, etc., but no definitive controlled studies have been conducted in pregnant women.
In animal studies, the incidence of delayed ossification, skeletal abnormalities, and weight loss in pups was increased in pregnant rats when medium to high doses of dexzopiclone were applied, and no effects on the development of the embryo have been observed in experiments with rabbits.
No rigorously controlled studies have been conducted in pregnant women, and current drug data do not clarify the extent of the risk of miscarriage, adverse maternal and fetal outcomes, and major birth defects when dexzopiclone is administered to pregnant women, so patients are advised to use this product with caution as prescribed by their physician.
Dexzopiclone is mainly used for the treatment of insomnia, common adverse reactions include headache, viral infection, dyspepsia, nausea, dizziness, drowsiness, headache, unpleasant taste, etc. Patients with complex sleep behavior after taking the drug are prohibited, and patients who are allergic to the product are prohibited.
It is recommended that patients who are not feeling well go to a regular hospital in time and follow the doctor’s instructions for symptomatic treatment with medication.